Buscar
Mostrando ítems 1-10 de 74
Estrone And Estradiol Levels In Breast Cancer Patients Using Anastrozole Are Not Related To Body Mass IndexNíveis De Estrona E Estradiol Em Pacientes Com Câncer De Mama Usando Anastrozol Não Estão Relacionados Ao índice De Massa Corpórea
(Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, 2017)
Estrone And Estradiol Levels In Breast Cancer Patients Using Anastrozole Are Not Related To Body Mass IndexNíveis De Estrona E Estradiol Em Pacientes Com Câncer De Mama Usando Anastrozol Não Estão Relacionados Ao índice De Massa Corpórea
(Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016)
Short-term anastrozole therapy reduces Ki-67 and progesterone receptor expression in invasive breast cancer: a prospective, placebo-controlled, double-blind trial
(Springer, 2011-05-01)
The objective of this study was to compare Ki-67, Bcl-2, Bax, Bak, ER, and PgR expression in postmenopausal women with ER-positive invasive breast cancer (IBC) before and after short-term hormone therapy (HT) with either ...
Efecto del anastrozol en el desarrollo tumoral de glioblastoma multiforme en un modelo in vivo y un modelo in vitro
(Biblioteca Digital wdg.biblioUniversidad de Guadalajara, 2017-07-24)
El glioblastoma multiforme es la forma más común y agresiva de los tumores cerebrales primarios, se caracteriza por una alta heterogeneidad molecular que impide su tratamiento. La sobrevida de los pacientes, con estos ...
Adesão à terapia hormonal adjuvante com tamoxifeno e anastrozol em pacientes do Hospital São Paulo
(Universidade Federal de São Paulo, 2021-05-31)
Objetivo: Avaliar a adesão à terapia hormonal oral com tamoxifeno e anastrozol em pacientes atendidas no Ambulatório de Mastologia e no Ambulatório de Quimioterapia do Hospital São Paulo, Universidade Federal de São Paulo. ...
Estudo do biomarcador p16 no carcinoma de mama de mulheres submetidas à endocrinoterapia primária de curta duração com tamoxifeno e anastrozol
(Universidade Federal de São Paulo (UNIFESP), 2009-11-25)
Background: Frequent deletions or mutations of the INK4 gene, which encodes the cyclin-dependent kinase 4 inhibitor p16INK4a, have been documented in various human cancers, but little is known about the role of this tumor ...
Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients
(ELSEVIER SCIENCE INC, 2009)
Objective: To assess the effect of the aromatase inhibitor on patients with leiomyoma in the reproductive stage regarding reduction of uterine volume and control of symptoms. Design: Clinical study. Setting: Academic ...
Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil
(Associação Médica Brasileira, 2009-01-01)
OBJECTIVE: Breast cancer, a leading type of cancer in many developing countries, is the most frequent non-cutaneous tumor in Brazil. Hormone therapy is the standard of care in the adjuvant treatment of early-stage, ...